Bone Biologics Corporation (BBLG) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 805.05K | 733.11K | 715.27K | 748.08K | 1.04M | 1.55M | 951.02K | 809.66K | 903.54K | 1.16M | 2.08M | 3.04M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 663.46K | 475.91K | 527.47K | 556.47K | 614.91K | 450.37K | 521.27K | 459.22K | 657.91K | 712.93K | 506.04K | 744.62K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 141.6K | 257.2K | 187.81K | 191.61K | 423.58K | 1.1M | 429.75K | 350.44K | 245.63K | 447.08K | 1.57M | 2.29M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8 | -40 | 383 |
| Operating Income | -805.05K | -733.11K | -715.27K | -748.08K | -1.04M | -1.55M | -951.02K | -809.66K | -903.54K | -1.16M | -2.08M | -3.04M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 22.48% | 52.85% | 24.79% | 7.61% | -14.94% | -34.05% | 54.3% | 73.37% | 71.3% | 9.99% | -70.71% | -547.77% |
| EBITDA | -805.05K | -1.45M | 0 | -748.08K | -1.04M | -1.52M | -941K | -783.73K | -865.97K | -454.8K | 0 | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 22.48% | 4.82% | 100% | 4.55% | -19.92% | -234.59% | - | - | - | -128.01% | - | 100% |
| D&A (Non-Cash Add-back) | 0 | -715.27K | 715.27K | 0 | 0 | 0 | 0 | 0 | 0 | 705.2K | 2.08M | 3.04M |
| EBIT | -805.05K | -677.09K | -666.74K | -748.08K | -1.04M | -1.52M | -941K | -783.73K | -865.97K | -1.16M | -2.08M | -3.04M |
| Net Interest Income | 38.8K | 47.97K | 47.33K | 6.65K | 20.04K | 20.26K | 19.99K | 15.15K | 255 | 349 | 536 | 428 |
| Interest Income | 38.8K | 47.97K | 47.33K | 6.65K | 20.04K | 20.27K | 19.99K | 15.15K | 255 | 349 | 536 | 428 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 39.07K | 48.47K | 48.54K | 7.56K | 21.39K | 33.22K | 10.02K | 25.93K | 37.57K | -390K | 161.18K | 1.27M |
| Pretax Income | -765.99K | -684.64K | -666.74K | -740.52K | -1.02M | -1.52M | -941K | -783.73K | -865.97K | -1.55M | -1.92M | -1.77M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -765.99K | -684.64K | -666.74K | -740.52K | -1.02M | -1.52M | -941K | -783.73K | -865.97K | -1.55M | -1.92M | -1.77M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 24.69% | 55.01% | 29.15% | 5.51% | -17.45% | 1.82% | 50.99% | 55.7% | 76.66% | -273.48% | -57.51% | -276.94% |
| Net Income (Continuing) | -765.99K | -684.64K | -666.74K | -740.52K | -1.02M | -1.52M | -941K | -783.73K | -865.97K | -1.55M | -1.92M | -1.77M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.43 | -0.63 | -0.37 | -1.33 | -0.32 | -0.48 | -2.37 | -0.67 | -1.31 | 48.03 | -4.90 | -5.21 |
| EPS Growth % | -34.38% | -31.25% | 84.39% | -98.51% | 75.57% | -101% | 51.63% | 87.14% | 97.63% | -100% | 82.64% | 52.11% |
| EPS (Basic) | -0.43 | -0.63 | -0.37 | -1.33 | -0.32 | -0.48 | -2.37 | -0.67 | -1.31 | 48.03 | -4.90 | -5.21 |
| Diluted Shares Outstanding | 1.8M | 1.17M | 1.8M | 557.79K | 3.18M | 2.95M | 1.75M | 1.17M | 660.93K | 458.98K | 391.85K | 339.31K |
| Basic Shares Outstanding | 1.8M | 1.17M | 1.8M | 557.79K | 3.18M | 2.95M | 1.75M | 1.17M | 660K | 458K | 391K | 339K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |